Key takeaways
“In a regulated business, it is not enough to have behaved well. You must be able to show that you did, to someone who was not there.”
In most industries, Shadow AI is a risk to manage. In healthcare and financial services, it is a risk that regulators, auditors and patients or customers can hold you to account for. The information passing through these organisations — clinical notes, diagnoses, account details, trading positions, credit decisions — is the information the law treats most seriously. A well-meant prompt typed into an unapproved assistant can touch all of it. This guide is for leaders in healthcare, life sciences, banking, insurance and fintech who want to understand the specific exposure and build an approach that can withstand scrutiny.


When the Data Is a Patient or a Portfolio
Our introductory guide, What Is Shadow AI? A Business Leader's Guide to Unsanctioned AI Tools, defined Shadow AI and set out the general risks, so we will focus on what changes when the information in question is regulated. In most businesses a leaked document is an embarrassment and a contractual problem. In healthcare and finance it can also be a regulatory event, with duties to assess, notify and explain.
Consider the everyday tasks where generative AI is useful. A clinician wants a tidy summary of a long set of notes. A coder wants help interpreting a discharge report. A relationship manager wants a client briefing drafted from account history. An analyst wants a spreadsheet of positions explained. A compliance officer wants a regulatory circular condensed. Each is a legitimate task, and in each the raw material is exactly the kind of data these industries are obliged to protect.
What makes these sectors different is not that their people are less careful. It is that the cost of a single misjudgement is higher, the paper trail is expected to be complete, and the penalty for being unable to explain what happened can exceed the penalty for the event itself.
Why Regulated Teams Turn to Shadow AI Anyway
It would be reasonable to expect compliance-heavy cultures to be immune. They are not, for reasons that are easy to understand.
- The administrative burden is heavy. Clinical documentation, claims, reconciliations, reporting and know-your-customer reviews consume large amounts of skilled time. AI offers immediate relief from precisely this work.
- Approval cycles are slow, and rightly so. Careful vendor and risk assessment takes months. In the meantime the tools are free, instant and well publicised.
- Staff are conscientious about the wrong thing. People who would never email a patient file to a personal address may not recognise pasting an excerpt into a chat window as the same act.
- Policies pre-date the technology. Data handling rules were written around email, removable media and file sharing. They seldom name generative AI.
- Shadow AI arrives inside approved software. Assistants are increasingly built into productivity suites, electronic record systems and CRMs, so use can start with a settings change instead of a new purchase.
The standard institutional answer is either to wait for a perfect enterprise solution or to prohibit the tools. Waiting leaves the demand unmet. Prohibition tends to push use onto personal devices, where visibility is lowest. Neither addresses the underlying issue, which is that staff have a legitimate need and no governed way to meet it.
Where the Exposure Concentrates
The following is not exhaustive, and the specifics depend on your organisation. It shows the points where regulated data and unmanaged AI most often meet.
In healthcare and life sciences
- Clinical documentation and summarisation. Notes, referral letters and discharge summaries contain identifiable health information, often among the most sensitive categories of personal data.
- Coding, billing and claims. Staff may paste records to speed up interpretation or query drafting.
- Research and trial data. Study protocols, participant information and unpublished findings carry confidentiality and integrity obligations.
- Patient communications. AI-drafted messages can contain errors that a clinician would have caught, with consequences for care.
See how our work with healthcare and life sciences organisations approaches this balance between automation and protection.
In financial services and fintech
- Client and account data. Customer records, transaction histories and identity documents submitted for summarisation or analysis.
- Market-sensitive information. Deal information, positions, research drafts and internal views that are not public.
- Decision support. Credit, underwriting or advice-related material drafted with AI without any record of how a conclusion was reached.
- Regulatory submissions. Reports and responses to supervisors where inaccuracy or unexplained provenance is itself a problem.
Our page on financial services and fintech sets out how Prospiretech works within these constraints.


Mapping the Rules Without Becoming a Lawyer
Every organisation needs qualified legal and compliance advice on its own obligations, and this section is general information, not legal advice. Its purpose is to help you ask the right questions of your advisers.
Questions to put to your compliance team
- Health data frameworks. If you handle health information, which frameworks apply — for example the United States HIPAA regime if you serve US patients or partners, or India's Digital Personal Data Protection Act for personal data processed in India? What do they say about disclosure to service providers and about safeguards, and does an unapproved AI service fall within that scope?
- Financial sector regulators. Which expectations apply from regulators such as the Reserve Bank of India or the Securities and Exchange Board of India, covering outsourcing, data localisation, cybersecurity, record-keeping and the supervision of technology used in regulated activities? Many such regimes expect firms to maintain control and accountability over third parties handling their data.
- Cross-border considerations. Does data entered into an AI service leave the country, and do any localisation or transfer restrictions apply?
- Contractual overlays. What do client, payer, partner and trial-sponsor agreements require about third-party processing?
- Evidence. If a regulator or auditor asked how you govern AI use today, what could you show them?
Regulatory expectations on AI are developing, and they differ between jurisdictions and over time. Rather than building controls around a single rulebook, build them around the common principles — purpose limitation, security, third-party accountability, record-keeping and human oversight — which are likely to hold as specific rules evolve.
A Governance Model Built for Scrutiny
A model for regulated industries differs from a general one mainly in how much evidence it produces and how much it keeps inside your own boundary.
- Tier use by data and consequence. Distinguish tasks involving public content, internal content, personal data and regulated or clinical or market-sensitive data, and tie permitted AI routes to each tier.
- Keep regulated workloads in a controlled environment. Use models accessed under enterprise terms, deployed within your own cloud, and connected to your systems through reviewed integrations. An autonomous AI agent that handles a defined task end to end, with its permissions and logs, is easier to assess than countless individual chat sessions.
- Apply checks at submission and keep the record. Rules that pass, flag or escalate a request before it reaches a model, with an audit log of each decision, give you the traceability that supervisors expect.
- Preserve human oversight. Make clear which outputs require clinical or professional review before use, and record that review.
- Be ready for security review. Single sign-on, role-based access, tenant separation and automated, repeatable deployment are the foundations of passing procurement and audit scrutiny. Cloud and DevOps engineering and managed services keep them in place after launch. For a related example of designing these foundations in from the start, see Making a Multi-Tenant SaaS Platform Enterprise-Ready from the Ground Up, delivered for an enterprise SaaS company in the USA.
- Review on a schedule. Re-assess tools, tiers and regulatory developments at least quarterly, and after any significant incident or change.
Making a Multi-Tenant SaaS Platform Enterprise-Ready from the Ground Up
Regulated buyers scrutinise security questionnaires, SSO requirements and data isolation before they sign. Prospiretech was the end-to-end development partner for an enterprise SaaS company in the USA that builds AI governance tools for large enterprise customers, responsible for both the product and its infrastructure. The platform was containerised with Docker, released through an automated GitHub Actions pipeline, built with data isolation per tenant at the database level, and architected to be Okta SSO/SAML-ready from the start. This does not mean the platform was built for healthcare or banking specifically, but it shows how the security foundations that regulated customers ask for can be designed in rather than retrofitted, by the same team that built the product.
- The platform passed enterprise security review without any architectural changes after delivery
- New enterprise tenants can be onboarded without infrastructure changes, because isolation is built in
- Enterprise customers can connect their own identity provider without requiring additional engineering
- Releases are fully automated, with no deployment window to coordinate
Frequently Asked Questions
Does using ChatGPT with patient data breach HIPAA?
It depends on the facts, and you should take advice from qualified counsel. In general terms, health data frameworks restrict disclosing protected information to service providers without appropriate safeguards and agreements, and consumer AI services typically do not offer the arrangements a healthcare organisation would need. Whether a specific act amounts to a violation depends on what was shared, with whom and under what terms. The safer route is to provide approved tools and ban sharing identifiable data with unapproved ones.
How do financial regulators view employee use of AI tools?
Regulators such as the Reserve Bank of India and the Securities and Exchange Board of India publish expectations on outsourcing, cybersecurity, data handling and record-keeping, and these are generally understood to apply regardless of the technology involved. Detailed AI-specific requirements are still developing and vary by jurisdiction. Confirm current obligations with your compliance team. The common principle is that the firm remains accountable for data and decisions, even when a third-party tool is used.
Can regulated organisations use generative AI at all?
Yes, and many do, with controls. The pattern is to use tools under enterprise terms, keep sensitive processing inside a controlled environment, apply policy checks at the point of use, retain audit logs and ensure human review of consequential outputs. The aim is not zero AI but governed AI. Organisations that provide this tend to find that unsanctioned use falls, because staff have a route that meets their needs. Start small.
What evidence will auditors or supervisors expect?
Expectations vary, but they commonly include an inventory of AI tools and use cases, a risk assessment, policies and training records, vendor due diligence, access controls, logs showing how requests were handled, and evidence of human oversight. The absence of any record is often more damaging than an imperfect one. Ask your compliance team what would be requested in your sector and build the logging to produce it. Rehearse the request before it arrives.
Where should a hospital or financial institution start?
With a short discovery exercise covering which tools are in use, by which teams and with what data, followed by a risk tiering of use cases. Prioritise the highest-sensitivity workflows for replacement with governed alternatives, and put quick wins in lower-risk areas to show staff that approved options exist. Involve compliance, legal, IT and clinical or business leads from the outset, and review progress quarterly. Keep the programme proportionate to risk.
Govern AI the way your regulators will expect you to
Prospiretech helps healthcare and financial services organisations replace unmanaged AI use with governed tools, secure infrastructure and the audit evidence that scrutiny demands. Start with a complimentary 30-minute consultation.
